tiprankstipranks
Minerva Neurosciences (NERV)
NASDAQ:NERV
US Market
NERV
Minerva Neurosciences
RESEARCH TOOLSreports
Want to see NERV full AI Analyst Report?

Minerva Neurosciences (NERV) Stock News & Sentiment

618 Followers
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
Premium
Company Announcements
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
7d ago
NERV
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
Premium
Ratings
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
11d ago
NERV
NERV Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NERV Earnings this Week: How Will it Perform?
18d ago
NERV
Minerva Neurosciences Sets 2026 Annual Shareholder Meeting Timeline
Premium
Company Announcements
Minerva Neurosciences Sets 2026 Annual Shareholder Meeting Timeline
2M ago
8K
NERV
Minerva Neurosciences Appoints New Chief Business Officer, Counsel
Premium
Company Announcements
Minerva Neurosciences Appoints New Chief Business Officer, Counsel
2M ago
8K
NERV
Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
Premium
Market News
Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
2M ago
MU
MSS
Minerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises
Premium
Company Announcements
Minerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises
2M ago
NERV
More NERV News >

NERV News on the Web

Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
TipRanks News
Neutral
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
TipRanks News
Neutral
NERV Earnings this Week: How Will it Perform?
TipRanks News
Neutral
Minerva initiated with an Outperform at Citizens
TipRanks News
Bullish
Minerva Neurosciences Sets 2026 Annual Shareholder Meeting Timeline
TipRanks News
Neutral
Minerva Neurosciences Appoints New Chief Business Officer, Counsel
TipRanks News
Neutral
Minerva appoints Jim O’Connor as chief business officer
TipRanks News
Neutral
Minerva screens first patient in roluperidone trial
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
NERV
Sector Average
Media Buzz
This Week2 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average81%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NERV’s Media Buzz Sentiment?
2 articles about NERV were published this week. In an average week, 0.75 articles are published.
    What is NERV’s weekly average amount of articles?
    In an average week, 0.75 articles about NERV are published.
      What is NERV’s News Sentiment?
      100% of articles about NERV were positive this week, compared to its sector average of 81%.
        Healthcare Stocks that are Trending in the News
        YSWYYesway Inc Class A
        XEX-Energy, Inc. Class A
        NHPNational Healthcare Properties
        MRVMarvell Technology Inc Sponsored Canadian Depository Receipt Hedged
        0FINOrkla ASA
        Showing the stocks with the most bullish news sentiment over the past week